Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OC Lugo is a specialty chemical manufacturing company focused on chemical oxygen generation systems, absorbents, catalysts, and carbons rather than a therapeutic biotech or pharmaceutical pipeline. The company supplies sodium chlorate-based chemical oxygen generator devices used to produce breathable oxygen in enclosed environments, particularly for U.S. Navy submarine applications. It also markets products for industrial purification, diving carbon dioxide absorbents, respiratory absorbents, and healthcare soda lime. Founded in 1973, the business was acquired by Molecular Products Group in October 2019 and continues to operate as an acquired operating business. For a biotech analyst, this is best classified as a specialty chemicals and defense-adjacent industrial company with some healthcare-adjacent consumables, not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OC Lugo.